Implications of comorbidity on costs for patients with Alzheimer disease.
about
Direct and indirect cost of managing alzheimer's disease and related dementias in the United States.Dementia and co-occurring chronic conditions: a systematic literature review to identify what is known and where are the gaps in the evidence?Cohort Study on Predictors of Need for Nursing Care in Alzheimer's Disease: An Analysis of Healthcare Data.Comorbidity and polypharmacy in people with dementia: insights from a large, population-based cross-sectional analysis of primary care data.Healthcare costs and utilization for Medicare beneficiaries with Alzheimer'sA systematic review to assess the policy-making relevance of dementia cost-of-illness studies in the US and Canada.Interactive Effects of Dementia Severity and Comorbidities on Medicare Expenditures.Factors associated with time to identify physical problems of nursing home residents with dementia.Alzheimer's disease: a healthcare burden of epidemic proportion.Comorbidity and dementia: a scoping review of the literature.Failure to identify behavioral symptoms of people with dementia and the need for follow-up physical assessment.Patterns of health service use in community living older adults with dementia and comorbid conditions: a population-based retrospective cohort study in Ontario, CanadaMethodological challenges in assessing the impact of comorbidities on costs in Alzheimer's disease clinical trialsSevere potential drug-drug interactions in older adults with dementia and associated factors.Effects of general medical health on Alzheimer's progression: the Cache County Dementia Progression StudyImaging the Alzheimer brain.Caregiver burden, health utilities, and institutional service costs among community-dwelling patients with Alzheimer disease.Deaths in the United States among persons with Alzheimer's disease (2010-2050)Dementia care costs and outcomes: a systematic review.The clinical and economic burden of newly diagnosed Alzheimer's disease in a medicare advantage population.Medicare Expenditures Associated With Hospital and Emergency Department Use Among Beneficiaries With Dementia.Effects of cognition, function, and behavioral and psychological symptoms on out-of-pocket medical and nursing home expenditures and time spent caregiving for persons with dementia.Development and Testing of a Measure of Caregiver Confidence in Medical Sign/Symptom Management.Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After Diagnosis.Bupropion and Citalopram in the APP23 Mouse Model of Alzheimer's Disease: A Study in a Dry-Land Maze.Health disparities in cost of care in patients with Alzheimer's disease: an analysis across 4 state Medicaid populations.Helping Dementia Caregivers Manage Medical Problems: Benefits of an Educational Resource.Lower Postsurgical Mortality for Individuals with Dementia with Better-Educated Hospital Workforce.Comorbidity and the rate of cognitive decline in patients with Alzheimer dementia.Donepezil may reduce the risk of comorbidities in patients with Alzheimer's disease: A large-scale matched case-control analysis in Japan.
P2860
Q30235057-B9CA7677-D6D5-4E20-B77F-7288820F34FCQ30238668-3B4B7353-3DBA-403F-89C9-B5BCA303D14DQ31132763-7B05F19E-C670-48F6-823A-769F458BE89BQ31160667-BEC54977-2CF6-446F-8579-1F72E18E0016Q33156304-2DEE3D7F-8B03-4613-8E2C-C0439729E9C0Q33751490-6552C184-BD9B-4908-9981-96552B825BB9Q33769928-BC916754-AAEF-4D01-BEB1-4F4EBAA9A71FQ33907668-BA3597DB-EF6B-44DE-ACEE-022D96052C86Q33932371-54107710-2784-494D-BB0A-E1109800207CQ34499517-AD294866-F9A9-4B3E-AFF4-EA9AD5A2E632Q35179550-0D75BF02-C270-4B50-B980-33D2033C770AQ36175328-B2996EF7-CB8D-4C76-BAE9-C374373F0174Q36285087-642ED2C8-A169-4EAF-8FD5-6740CA1CED1BQ36605731-27A653D2-4BD0-4C78-A271-ECA0DFA81742Q36613964-3A43BE87-B718-4534-95F5-F324A7B063F3Q37141502-461482FE-CED1-4B86-AA08-C6AAD25AE694Q37632766-012AE599-0941-46EE-9E67-3AE653A1BAD0Q37686827-4686EA2A-7DDD-49A0-91D5-06380351519DQ38034164-7267739B-F7D2-45B9-B465-92EB64E8F6EBQ38107921-A33279B4-0EDB-41DD-972D-32FFC4CB5CCDQ38902939-D5479F00-83CC-4EF0-A7F9-ACC2707CE50DQ38979035-1365918A-1AE5-4BCB-95C2-0AA22ABAF852Q39338681-09849518-0D79-4291-9BE8-0BD97EA3F457Q39687779-FB1E9207-721C-4DD8-A30E-5F3596B5F794Q41860053-4868CD60-BFCD-49A8-9B37-AFD8F7798059Q44315227-CDF6E9C8-793E-4AE7-A62A-B5FBB539AA13Q47208908-881ADAD4-F13B-4E96-BC70-A9590FE641DBQ52646626-5747583D-AC3F-4779-97DD-651B8D517847Q53318360-0A68F248-E1B9-487C-B7A2-3AD43879CAF3Q55493454-F07C2E61-14E7-4D7A-B668-01F2740B53DB
P2860
Implications of comorbidity on costs for patients with Alzheimer disease.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Implications of comorbidity on costs for patients with Alzheimer disease.
@en
Implications of comorbidity on costs for patients with Alzheimer disease.
@nl
type
label
Implications of comorbidity on costs for patients with Alzheimer disease.
@en
Implications of comorbidity on costs for patients with Alzheimer disease.
@nl
prefLabel
Implications of comorbidity on costs for patients with Alzheimer disease.
@en
Implications of comorbidity on costs for patients with Alzheimer disease.
@nl
P2093
P1433
P1476
Implications of comorbidity on costs for patients with Alzheimer disease.
@en
P2093
Arlene S Ash
Marilyn Schlein Kramer
Sharada Weir
Tzu-Chun Kuo
P304
P356
10.1097/MLR.0B013E318178940B
P577
2008-08-01T00:00:00Z